1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Salivary Gland Cancer Global Clinical Trials Review, H1, 2015

Salivary Gland Cancer Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Salivary Gland Cancer Global Clinical Trials Review, H1, 2015" provides data on the Salivary Gland Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Salivary Gland Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Salivary Gland Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Salivary Gland Cancer Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Salivary Gland Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Salivary Gland Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Salivary Gland Cancer to Oncology Clinical Trials 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Salivary Gland Cancer 24
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Salivary Gland Cancer Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
AstraZeneca PLC 31
Clinical Trial Overview of AstraZeneca PLC 31
Bristol-Myers Squibb Company 32
Clinical Trial Overview of Bristol-Myers Squibb Company 32
Otsuka Holdings Co., Ltd. 33
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 33
Biotec Pharmacon ASA 34
Clinical Trial Overview of Biotec Pharmacon ASA 34
Clinical Trial Overview of Top Institutes / Government 35
National Cancer Institute 35
Clinical Trial Overview of National Cancer Institute 35
Fox Chase Cancer Center 38
Clinical Trial Overview of Fox Chase Cancer Center 38
University Health Network 39
Clinical Trial Overview of University Health Network 39
University of Washington 40
Clinical Trial Overview of University of Washington 40
Eastern Cooperative Oncology Group 41
Clinical Trial Overview of Eastern Cooperative Oncology Group 41
University of Chicago 42
Clinical Trial Overview of University of Chicago 42
University of Texas M. D. Anderson Cancer Center 43
Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center 43
Ontario Clinical Oncology Group 44
Clinical Trial Overview of Ontario Clinical Oncology Group 44
Stanford University 45
Clinical Trial Overview of Stanford University 45
Five Key Clinical Profiles 46
Appendix 80
Abbreviations 80
Definitions 80
Research Methodology 81
Secondary Research 81
About GlobalData 82
Contact Us 82
Disclaimer 82
Source 83

List of Tables
Salivary Gland Cancer Therapeutics, Global, Clinical Trials by Region, 2015* 7
Salivary Gland Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Salivary Gland Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Salivary Gland Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Salivary Gland Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Salivary Gland Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Salivary Gland Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Salivary Gland Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Salivary Gland Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Salivary Gland Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Salivary Gland Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Salivary Gland Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Salivary Gland Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Salivary Gland Cancer Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Salivary Gland Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Salivary Gland Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Salivary Gland Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Salivary Gland Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2015* 24
Salivary Gland Cancer Therapeutics, Global, Terminated Clinical Trials, 2015* 25
Salivary Gland Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Salivary Gland Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27
Salivary Gland Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Salivary Gland Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Salivary Gland Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
Salivary Gland Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 31
Salivary Gland Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015* 32
Salivary Gland Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2015* 33
Salivary Gland Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Biotec Pharmacon ASA, 2015* 34
Salivary Gland Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 35
Salivary Gland Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2015* 38
Salivary Gland Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2015* 39
Salivary Gland Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2015* 40
Salivary Gland Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Cooperative Oncology Group, 2015* 41
Salivary Gland Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Chicago, 2015* 42
Salivary Gland Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas M. D. Anderson Cancer Center, 2015* 43
Salivary Gland Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Ontario Clinical Oncology Group, 2015* 44
Salivary Gland Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2015* 45

List of Figures
Salivary Gland Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Salivary Gland Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Salivary Gland Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Salivary Gland Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Salivary Gland Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Salivary Gland Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Salivary Gland Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Salivary Gland Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Salivary Gland Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Salivary Gland Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Salivary Gland Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Salivary Gland Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Salivary Gland Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Salivary Gland Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Salivary Gland Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Salivary Gland Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Salivary Gland Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Salivary Gland Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27
Salivary Gland Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Salivary Gland Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Salivary Gland Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 81

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Colorectal Cancer KOL Insight 2016

Colorectal Cancer KOL Insight 2016

  • $ 8085
  • Industry report
  • October 2016
  • by Firstword Pharma

KOLs embrace novel MoAs as low survival rates drive search for new treatments Faced with persistently low survival rates, KOLs are calling for new approaches to treat late-stage colorectal cancer (CRC). ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.